Mayfair Advisory Group, LLC Abbott Laboratories Transaction History

Mayfair Advisory Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$114.02 - $139.04 $198,964 - $242,624	-1,745 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $13,863 - $16,975	-120 Reduced 6.43%	1,745 $236,000
Q3 2021 Oct 08, 2021	BUY	$116.66 - $129.06 $5,833 - $6,453	50 Added 2.75%	1,865 $215,000
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $10,579 - $12,453	-100 Reduced 5.22%	1,815 $210,000
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $208,428 - $245,560	1,915 New	1,915 $228,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Mayfair Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayfair Advisory Group, LLC with notifications on news.